Strong breast research group @utswcancer @UTSWMedCenter presence at Theresa’s Research Symposium/MBC DART! Great discussions and input on our work on how CDK4/6i reshapes DC immunity and exciting presentations by @MalladiLab @AriellaHanker @PrasannaAlluri @ithinkichan.
Excited to celebrate academic promotion to Associate Professor with @TiansterZhang, Tuoqi Wu and other colleagues at @UTSWMedCenter ! Congrats to everyone promoted this cycle!
Coming back from #SITC2026 with lots of new ideas! Exciting work on cancer vaccines, patient-derived models, and IL-12 delivery. Best of all the chance to catch up with friends and colleagues!
Grateful to have been part of this important work on dual immune checkpoint blockade in metastatic breast cancers! Congrats to all the authors!
The #NIMBUS trial results are now published in @NatureComms 👉Nivolumab plus low-dose #ipilimumab in hypermutated HER2-negative #MetastaticBreastCancer.
🔓pubmed.ncbi.nlm.nih.gov/4036…
✍️@jgtzanudo @smreddymd @EmensLeisha @CarolinaAlvesC5 @s_aldubayan @hoyin_chu @nlinmd
@NabihahTayob @RMJesel @EMittendorfMD
@stolaney1
2
344
Sangeetha Reddy retweeted
#AACR25, capturing the last night at AACR grantee award reception along with @utswcancer colleague @smreddymd ! Managed to take a photo with the one and only @AACR_CEO !Thanks the grant support from @AACR @kidneycan
Sangeetha Reddy retweeted
Big congratulations @smreddymd @utswcancer !!
We congratulate Sangeetha Reddy, MD, recipient of a 2024 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in Partnership with Pelotonia & AACR. Dr. Reddy will study the impact of CD40 agonists on the myeloid CD8 T cell axis.
@VictoriasSecret @Pelotonia
Sangeetha Reddy retweeted
Replying to @UTSWInternalMed
@UTSWInternalMed #GrandRounds with @smreddymd highlighting immunotherapy for breast cancer and her translational efforts. Our breast cancer team is strong @utswcancer @UTSWHemeOnc! @CarlosArteagaMD @suzanneconzenmd @hmcarthur
Big congrats!!!
Read it here: cell.com/cell-reports-medici… Happy to talk more- How can we use our lab's tools & data to help you?
Led by Lily Xu @UTSWMedCenter Med student, Katilyn Saunders, and Shawn Huang @UTSWmstp. 🙏 to funders @SusanGKomen @metavivor @theNCI. Collab w/ @GRASPtweets who gave *great* patient insight & Lin Xu, @smreddymd @hmcarthur @utswcancer, & my dear friend who knows @tomhanks @RoussosTorres. @UTSWHemeOnc @BiotechClubUTSW @UTSWInternalMed @UTSWCancerBio @CellRepMed
1
3
669
Excited to share our updated pre-clinical data on combination CD40 agonist + Flt3L + Doxil in breast cancer with @PreteeshLeo. @utswcancer #aacr24
Sangeetha Reddy retweeted
#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer @DrRBarroso @stolaney1 @nlinmd @nabihahtayob @emittendorfmd @RMJesel @smreddymd
Sangeetha Reddy retweeted
After my wonderful experience at @MDAndersonNews, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research. #SABCS23 – at San Antonio, TX
Sangeetha Reddy retweeted
Tumor Agnostic Approaches to Care: @VivekSubbiah, Joshua Z. Drago, @DrMiaLevy, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23.
@lab_kok @smreddymd @AACR @UTHealthSAMDA @OncoAlert
Looking forward to moderating this session and hearing some stellar talks in Stars at Night Ballroom in just a few minutes! @SABCSSanAntonio @utswcancer #sabcs23
Join us for tumor-agnostic session @SABCSSanAntonio #SABCS23. What can we as BC physicians and investigators learn from other tumor types and how best to collaborate! With stellar speakers @VivekSubbiah
Sangeetha Reddy retweeted
The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes & failures of cancer #immunotherapy doi.org/10.1016/j.immuni.202…
Sangeetha Reddy retweeted
It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’
Both
The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness
Great paper @ESMO_Open @DrJonLim
esmoopen.com/article/S2059-7…
Sangeetha Reddy retweeted
Highlighting the important role the innate immune system plays in immunotherapy, @smreddymd delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast jitc.bmj.com/content/11/5/e0…
Starting Now: Immunotherapy in Breast Cancer - (Vaccine Strategies). Moderated by: Vered Stearns #DAVAHawaiiBreast
Excited to share our work with @avilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade!
jitc.bmj.com/content/11/5/e0…
We did it! 7 mo of training, 9 days of hiking in the mountains, the hardest thing by far I’ve done to peak Mt Kilimanjaro…soaring above the clouds & making new family along the way…learned anything can be done by going pole pole (slow) one step at a time! An amazing experience!














































